Multisite Implementation of COMPRENDO
a study on Cancer, General
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting implementation. This study will test the impact of COMPRENDO, a peer-navigation intervention, vs. usual care on accrual to childhood cancer therapeutic clinical trials and parental informed consent outcomes. COMPRENDO will be delivered by trained peer navigators in 4 visits. A mixed methods (surveys, individual interviews) implementation evaluation will examine implementation factors that can inform the use of peer navigation in clinical practice, integrating data from clinicians, navigators, administrators, and parents pre and post the RCT.
Official Title
Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to Improve Participation of Hispanic Children in Cancer Clinical Trials
Details
Aim 1:
Test the effectiveness of COMPRENDO vs. usual care to increase clinical trial accrual in a multisite RCT.
Aim 2:
Determine the impact of COMPRENDO vs. usual care on parental outcomes (informed consent, comprehension, voluntariness, decision-making self-efficacy, satisfaction with informed consent and decisional regret).
Aim 3:
Evaluate multisite implementation of COMPRENDO, focusing on acceptability, feasibility, and fidelity. We will use mixed methods with a minimum of 50 stakeholders: 22 clinicians, (17 oncologists, 3 psychologists, 2 social workers), 4 navigators, 4 administrators and 20 parents to identify implementation factors.
Within each site, eligible participants will be randomized 1:1 to the intervention vs. usual care (informed consent discussion with the oncologist only), resulting in ≈200 participants randomized to each arm.
Keywords
Pediatric Cancer, Research Literacy, Cancer Disparities, Minority Clinical Trial Accrual, Patient Navigation, COMPRENDO Peer Navigation Intervention
Eligibility
For people ages 18 years and up
Participants (n≈400) will be parents of Hispanic children (0-17 years) with newly diagnosed cancer or cancer-like disease (histiocytic disorders or myelodysplastic syndromes) and eligible for a therapeutic clinical trial who meet the following inclusion criteria:
- are a Hispanic parent/primary legal guardian;
- has a child aged 0 to 17 y with a new diagnosis of cancer or cancer-like disease (histiocytic disorders or myelodysplastic syndromes);
- has a child who is eligible for a therapeutic cancer clinical trial;
- will participate in an informed consent discussion for the therapeutic clinical trial;
- has an understanding of written and spoken English or Spanish;
- has signed the consent form for the proposed COMPRENDO study.
Parent Exclusion Criteria:
- second malignancy/relapse;
- diagnosed at an outside institution;
- potential transfer of care to another institution within the next 4 months;
- previously on a clinical trial;
- does not understand written and spoken English or Spanish;
- not Hispanic.
Stakeholder Inclusion Criteria:
Clinicians and parents of children with cancer who have participated in IC discussion for a cancer therapeutic clinical trial.
Stakeholder Exclusion Criteria:
Clinicians and parents of children with cancer who have not participated in IC discussion for a cancer therapeutic clinical trial.
Locations
- UCSF Benioff Children's Hospitals
accepting new patients
San Francisco California 94609 United States - Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center
accepting new patients
San Diego California 92123 United States - Children's of Alabama/University of Alabama at Birmingham
not yet accepting patients
Birmingham Alabama 35243 United States - Dana Farber Cancer Institute/Boston Children's Hospital
not yet accepting patients
Boston Massachusetts 02115 United States
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT06055296
- Study Type
- Interventional
- Participants
- Expecting 450 study participants
- Last Updated
Frequently Asked Questions
Please contact me about this study
We will not share your information with anyone other than the team in charge of this study, which might include an external sponsor. Submitting your contact information does not obligate you to participate in research.
Thank you!
The study team should get back to you in a few business days.
You will also receive an email with next steps. Check your junk/spam folder if needed.
If you do not hear from the study team, please call 888-689-8273 and tell them you’re interested in study number NCT06055296.